Home / Safety / Ennov for the pharmaceutical industry

Ennov (Paris, France)

How safe is Ennov for the pharmaceutical industry?

GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is certification or a GDPR guarantee (1) and whether the provider is established in the NL or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure for the pharmaceutical industryLimited

Ennov publishes limited privacy safeguards. Ask the provider for clarification before you put confidential pharmaceutical industry data into it.

Where does Ennov stand in the pharmaceutical industry?

Shared place 9 of 25 options for the pharmaceutical industry (professional tools and general assistants) on GDPR profile. 7 options, like Ennov's profile, are limited. Each tile is an option we track for this field; click through for the check.

Strong5
Good3
Limited7
Unknown3
Caution7

Stronger or equally strong in the pharmaceutical industry

Questions

How safe is Ennov for the pharmaceutical industry?
Ennov publishes limited privacy safeguards. Ask the provider for clarification before you put confidential pharmaceutical industry data into it. Limited or partly unknown safeguards, check with the provider.
Does Ennov train on my data?
It is not public which models 'Ennov AI' uses. Cloud or on-premises; hosting available as a service.
What should I look out for with AI in the pharmaceutical industry?
This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.

Source documents

Everything about Ennov Best AI for the Pharmaceutical Industry

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 3 November 2026 · How we check

Every Friday: what changed in AI for the pharmaceutical industry

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.